Here are two such growth stocks that Wall Street rates as a “Strong Buy” and believes will generate more than 300% returns ...

Babies treated with antibiotics in the first few weeks of their life are likely to show weaker immune responses to essential ...

Immunization programs save millions of lives every year by protecting against preventable diseases. The immune response to ...

Meanwhile, the launch of new-generation innovative products, including the serum-free rabies vaccine, the 13-valent pneumococcal conjugate vaccine, the quadrivalent meningococcal conjugate vaccine, as ...

Meanwhile, the launch of new-generation innovative products, including the serum-free rabies vaccine, the 13-valent pneumococcal conjugate vaccine, the quadrivalent meningococcal conjugate vaccine ...

a 24-valent pneumococcal conjugate vaccine to prevent invasive pneumococcal disease. The vaccine holds significant potential to become a best-in-class PCV in a $7 billion global market expected to ...

Merck, known as MSD outside of the United States and Canada, announced that the European Commission (EC) has approved Capvaxive (Pneumococcal 21-valent Conjugate Vaccine) for active immunization for ...